{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:41:54Z","timestamp":1772894514895,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001258","name":"National Kidney Foundation of Louisiana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.amjms.2021.05.017","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:44:45Z","timestamp":1621838685000},"page":"453-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4"],"prefix":"10.1016","volume":"362","author":[{"given":"Sixto","family":"Giusti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folarin","family":"Sogbetun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazih","family":"Nakhoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vecihi","family":"Batuman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjms.2021.05.017_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.ajkd.2019.07.012","article-title":"Proton pump inhibitors and the kidney: implications of current evidence for clinical practice and when and how to deprescribe","volume":"75","author":"Al-Aly","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.amjms.2021.05.017_bib0002","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.amjms.2021.05.017_bib0003","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","article-title":"Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury","volume":"91","author":"Xie","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.amjms.2021.05.017_bib0004","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2125.2007.02927.x","article-title":"Proton pump inhibitor-induced acute interstitial nephritis","volume":"64","author":"Harmark","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.amjms.2021.05.017_bib0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0002-9343(92)90181-A","article-title":"Acute interstitial nephritis due to omeprazole","volume":"93","author":"Ruffenach","year":"1992","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.amjms.2021.05.017_bib0006","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1440-1797.2006.00651.x","article-title":"Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases","volume":"11","author":"Simpson","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1016\/j.amjms.2021.05.017_bib0007","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/ndt\/gfh137","article-title":"Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit","volume":"19","author":"Torpey","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.amjms.2021.05.017_bib0008","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/j.gastro.2017.05.046","article-title":"Association between proton pump inhibitor use and risk of progression of chronic kidney disease","volume":"153","author":"Klatte","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjms.2021.05.017_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14157","article-title":"Acid-suppressive drugs and risk of kidney disease: a systematic review and meta-analysis [e-pub ahead of print]","author":"Qiu","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.amjms.2021.05.017_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204231","article-title":"Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort","volume":"13","author":"Rodriguez-Poncelas","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.amjms.2021.05.017_bib0011","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1681\/ASN.2015121377","article-title":"Proton pump inhibitors and risk of incident CKD and progression to ESRD","volume":"27","author":"Xie","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.amjms.2021.05.017_bib0012","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","article-title":"Proton pump inhibitors are associated with increased risk of development of chronic kidney disease","volume":"17","author":"Arora","year":"2016","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.amjms.2021.05.017_bib0013","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","article-title":"Proton pump inhibitors: review of emerging concerns","volume":"93","author":"Nehra","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.amjms.2021.05.017_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199160","article-title":"Proton pump inhibitoras an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis","volume":"13","author":"Okamoto","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.amjms.2021.05.017_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2021.05.017_bib0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ndt\/gfw470","article-title":"The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis","volume":"33","author":"Nochaiwong","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"3 Pt 2","key":"10.1016\/j.amjms.2021.05.017_bib0017","first-page":"F363","article-title":"Renal expression of the gene encoding the gastric H(+)-K(+)-ATPase beta-subunit","volume":"268","author":"Callaghan","year":"1995","journal-title":"Am J Physiol"},{"issue":"7","key":"10.1016\/j.amjms.2021.05.017_bib0018","doi-asserted-by":"crossref","first-page":"F693","DOI":"10.1152\/ajprenal.00605.2013","article-title":"H-K-ATPase type 2: relevance for renal physiology and beyond","volume":"306","author":"Crambert","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.amjms.2021.05.017_bib0019","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00041552-199909000-00011","article-title":"H+, K+-ATPase","volume":"8","author":"DuBose","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1 Pt 2","key":"10.1016\/j.amjms.2021.05.017_bib0020","first-page":"F1","article-title":"Function and structure of H-K-ATPase in the kidney","volume":"269","author":"Wingo","year":"1995","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1016\/j.amjms.2021.05.017_bib0021","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MNH.0b013e32833ce65f","article-title":"The renal H,K-ATPases","volume":"19","author":"Greenlee","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"10.1016\/j.amjms.2021.05.017_bib0022","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2215\/CJN.07400715","article-title":"Acid-base homeostasis","volume":"10","author":"Hamm","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.amjms.2021.05.017_bib0023","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.2001.281.4.F763","article-title":"Detection and localization of H+-K+-ATPase isoforms in human kidney","volume":"281","author":"Kraut","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.amjms.2021.05.017_bib0024","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.sapharm.2019.08.032","article-title":"Demographic and health-related predictors of proton pump inhibitor (PPI) use and association with chronic kidney disease (CKD) stage in NHANES population","volume":"16","author":"Devraj","year":"2020","journal-title":"Res Social Adm Pharm"},{"issue":"9","key":"10.1016\/j.amjms.2021.05.017_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203878","article-title":"Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amjms.2021.05.017_bib0026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ackd.2017.06.005","article-title":"Adverse effects of the metabolic acidosis of chronic kidney disease","volume":"24","author":"Kraut","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1016\/j.amjms.2021.05.017_bib0027","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ajkd.2015.08.028","article-title":"Metabolic acidosis of CKD: an update","volume":"67","author":"Kraut","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.amjms.2021.05.017_bib0028","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","article-title":"Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis","volume":"14","author":"Navaneethan","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.amjms.2021.05.017_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1681\/ASN.2019070677","article-title":"Mechanisms of metabolic acidosis-induced kidney injury in chronic kidney disease","volume":"31","author":"Wesson","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.amjms.2021.05.017_bib0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/qjmed\/hcz166","article-title":"Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis","volume":"112","author":"Grant","year":"2019","journal-title":"QJM"},{"issue":"20","key":"10.1016\/j.amjms.2021.05.017_bib0031","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.3390\/ijms20205203","article-title":"Adverse effects of proton pump inhibitors-evidence and plausibility","volume":"20","author":"Fossmark","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.amjms.2021.05.017_bib0032","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF00543501","article-title":"Omeprazole, a gastric \u2018proton pump inhibitor\u2019: lack of effect on renal handling of electrolytes and urinary acidification","volume":"26","author":"Howden","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"issue":"18","key":"10.1016\/j.amjms.2021.05.017_bib0033","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.2169\/internalmedicine.51.7981","article-title":"Distal renal tubular acidosis that became exacerbated by proton pump inhibitor use","volume":"51","author":"Okamoto","year":"2012","journal-title":"Intern Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921001877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921001877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:39:23Z","timestamp":1757702363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921001877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0002962921001877"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.05.017","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}